A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Ironwood Pharmaceuticals, Inc.
Start Date
October 9, 2018
End Date
July 31, 2021
Administered By
Medicine, Gastroenterology
Awarded By
Ironwood Pharmaceuticals, Inc.
Start Date
October 9, 2018
End Date
July 31, 2021